ClinicalTrials.Veeva

Menu

Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Completed

Conditions

Coronary Syndrome

Treatments

Other: Biological analysis of biomarkers

Study type

Interventional

Funder types

Other

Identifiers

NCT00769574
2008-A00192-53

Details and patient eligibility

About

To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).

Enrollment

143 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • subjects over 18 years,
  • subject about having a chest pain of coronary syndrome,
  • subject about not having received heparin or LMWH

Exclusion criteria

  • subject minor
  • subject without informed consent,
  • subject after receiving an anticoagulant treatment,
  • transplanted heart, kidney or liver

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

143 participants in 2 patient groups

1
Experimental group
Description:
Patients with coronary syndrome
Treatment:
Other: Biological analysis of biomarkers
Other: Biological analysis of biomarkers
2
Other group
Description:
Subjects without coronary syndrome
Treatment:
Other: Biological analysis of biomarkers
Other: Biological analysis of biomarkers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems